Describe your firm’s approach to litigation and your strategy for building successful teams for trials or other matters. What makes our group unique is our passion and enthusiasm. We don’t care about egos or about seniority; all we care about is getting our client the best result possible. This attitude affects every aspect of our work from how we develop case strategies to building our team. It is not uncommon for a partner to call a second-year associate to get a fresh approach to an issue or argument, or defer to a younger attorney’s strategy. We are successful because everyone in our group is equally engaged and influential and we all listen to and learn from each other.

Discuss the two biggest products liability/mass torts litigation cases your firm worked on in 2019 and how you reached successful outcomes. Johnson & Johnson faced a lawsuit seeking $5 billion in damages by a woman who alleged that baby powder use caused her to develop ovarian cancer. We handled the trial in a notoriously plaintiff-friendly jurisdiction, with very loose evidentiary rules that allowed plaintiffs to change experts at the last minute and introduce evidence about a recent voluntary product recall. Undeterred by the bad odds, we focused on the science, urged the jury to think for itself and evaluate the evidence without being influenced by plaintiffs’ conspiracy theories, and convinced the jury to return a verdict for J&J. [The firm also represented] eClinicalWorks in a nationwide class action filed by the estates of two patients whose medical records supposedly contained inaccuracies as a result of alleged glitches in eCW’s software. We secured a district court dismissal based on lack of standing, and the [U.S. Court of Appeals for the First Circuit] affirmed.